Single dose adenovirus vectored vaccine induces a potent and long-lasting immune response against rabbit hemorrhagic disease virus after parenteral or mucosal administration

Angulo, 2007, Towards a unique and transmissible vaccine against myxomatosis and rabbit haemorrhagic disease for rabbit populations, Wildl. Res., 34, 567, 10.1071/WR06160 Babiuk, 2000, Adenoviruses as vectors for delivering vaccines to mucosal surfaces, J. Biotechnol., 83, 105, 10.1016/S0168-1656(00)00314-X Bertagnoli, 1996, Protection against myxomatosis and rabbit viral hemorrhagic disease with recombinant myxoma viruses expressing rabbit hemorrhagic disease virus capsid protein, J. Virol., 70, 5061, 10.1128/JVI.70.8.5061-5066.1996 Bertagnoli, 1996, Protection of rabbits against rabbit viral haemorrhagic disease with a vaccinia-RHDV recombinant virus, Vaccine, 14, 506, 10.1016/0264-410X(95)00232-P Boga, 1997, A single dose immunization with rabbit haemorrhagic disease virus major capsid protein produced in Saccharomyces cerevisiae induces protection, J. Gen. Virol., 78, 2315, 10.1099/0022-1317-78-9-2315 Bouslama, 1996, Identification of the virus of rabbit haemorrhagic disease in Tunisia, Vet. Rec., 138, 108, 10.1136/vr.138.5.108 Calvete, 2006, Modeling the effect of population dynamics on the impact of rabbit hemorrhagic disease, Conserv. Biol., 20, 1232, 10.1111/j.1523-1739.2006.00371.x Capucci, 1998, A further step in the evolution of rabbit hemorrhagic disease virus: the appearance of the first consistent antigenic variant, Virus Res., 58, 115, 10.1016/S0168-1702(98)00106-3 Capucci, 1995, Antigenicity of the rabbit hemorrhagic disease virus studied by its reactivity with monoclonal antibodies, Virus Res., 37, 221, 10.1016/0168-1702(95)00033-M Casimiro, 2010, Efficacy of multivalent adenovirus-based vaccine against simian immunodeficiency virus challenge, J. Virol., 84, 2996, 10.1128/JVI.00969-09 Castañón, 1999, Immunization with potato plants expressing VP60 protein protects against Rabbit Haemorrhagic Disease Virus, J. Virol., 73, 4452, 10.1128/JVI.73.5.4452-4455.1999 Chasey, 1997, Rabbit haemorrhagic disease: the new scourge of Oryctolagus cuniculus, Lab. Anim., 31, 33, 10.1258/002367797780600279 Cooke, 2000, Use of ELISAs in field studies of rabbit haemorrhagic disease (RHD) in Australia, Epidemiol. Infect., 124, 563, 10.1017/S0950268899003994 Cooke, 2002, Rabbit haemorrhagic disease: field epidemiology and the management of wild rabbit populations, Rev. Sci. Tech., 21, 347, 10.20506/rst.21.2.1337 Dormond, 2009, From the first to the third generation adenoviral vector: what parameters are governing the production yield?, Biotechnol. Adv., 27, 133, 10.1016/j.biotechadv.2008.10.003 Farnós, 2005, High-level expression and immunogenic properties of the recombinant rabbit hemorrhagic disease virus VP60 capsid protein obtained in Pichia pastoris, J. Biotechnol., 117, 215, 10.1016/j.jbiotec.2005.01.013 Farnós, 2009, Biochemical and structural characterization of RHDV capsid protein variants produced in Pichia pastoris: advantages for immunization strategies and vaccine implementation, Antivir. Res., 81, 25, 10.1016/j.antiviral.2008.08.007 Farnós, 2007, Molecular and antigenic characterization of rabbit hemorrhagic disease virus isolated in Cuba indicates a distinct antigenic subtype, Arch. Virol., 152, 1215, 10.1007/s00705-006-0926-5 Fernández-Fernández, 2001, Protection of rabbits against rabbit hemorrhagic disease virus by immunization with the VP60 protein expressed in plants with a potyvirus based vector, Virology, 280, 283, 10.1006/viro.2000.0762 Ferreira, 2005, Use of adenoviral vectors as veterinary vaccines, Gene Ther., 12, 73, 10.1038/sj.gt.3302618 Fischer, 1997, A recombinant canarypox virus protects rabbits against a lethal rabbit hemorrhagic disease virus (RHDV) challenge, Vaccine, 15, 90, 10.1016/S0264-410X(96)00102-8 Forrester, 2006, Phylogenetic analysis of rabbit haemorrhagic disease virus strains from the Arabian Peninsula: did RHDV emerge simultaneously in Europe and Asia?, Virology, 344, 277, 10.1016/j.virol.2005.10.006 Gogev, 2002, Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD, Vaccine, 20, 1451, 10.1016/S0264-410X(01)00458-3 He, 1998, A simplified system for generating recombinant adenoviruses, Proc. Natl. Acad. Sci. U.S.A., 95, 2509, 10.1073/pnas.95.5.2509 Higgins, 1998, Introduction to Pichia pastoris Hoelscher, 2008, A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses, J. Infect. Dis., 197, 1185, 10.1086/529522 Hukowska-Szematowicz, 2009, Genetic variability of Czech and German RHD virus strains, Pol. J. Microbiol., 58, 237 Kim, 2010, Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection, Vaccine, 28, 3801, 10.1016/j.vaccine.2010.03.032 Laurent, 1994, Recombinant rabbit hemorrhagic disease virus capsid protein expressed in baculovirus self-assembles into virus like particles and induces protection, J. Virol., 68, 6794, 10.1128/JVI.68.10.6794-6798.1994 Liu, 2009, A high-yield and scaleable adenovirus vector production process based on high density perfusion culture of HEK 293 cells as suspended aggregates, J. Biosci. Bioeng., 107, 524, 10.1016/j.jbiosc.2009.01.004 Marchandeau, 2005, Serological evidence for a non-protective RHDV-like virus, Vet. Res., 36, 53, 10.1051/vetres:2004049 Marín, 1995, Immunogenic properties of rabbit haemorrhagic disease virus structural protein VP60 expressed by a recombinant baculovirus: an efficient vaccine, Virus Res., 39, 119, 10.1016/0168-1702(95)00074-7 McIntosh, 2007, A pandemic strain of calicivirus threatens rabbit industries in the Americas, Virol. J., 4, 96, 10.1186/1743-422X-4-96 Meeusen, 2007, Current status of veterinary vaccines, Clin. Microbiol. Rev., 20, 489, 10.1128/CMR.00005-07 Meneses-Acosta, 2008, Development of a suspension serum-free helper-dependent adenovirus production system and assessment of co-infection conditions, J. Virol. Methods, 148, 106, 10.1016/j.jviromet.2007.10.017 Montesino, 2008, Monosialylated biantennary N-glycoforms containing GalNAc-GlcNAc antennae predominate when human EPO is expressed in goat milk, Arch. Biochem. Biophys., 470, 163, 10.1016/j.abb.2007.11.019 Oem, 2009, Identification and characterization of rabbit hemorrhagic disease virus genetic variants isolated in Korea, J. Vet. Med. Sci., 71, 1519, 10.1292/jvms.001519 O’Keefe, 1999, Serology of rabbit haemorrhagic disease virus in wild rabbits before and after release of the virus in New Zealand, Vet. Microbiol., 66, 29, 10.1016/S0378-1135(98)00307-1 Pacheco, 2005, Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine, Virology, 337, 205, 10.1016/j.virol.2005.04.014 Parra, 1990, Purification of a calicivirus as the causative agent of a lethal hemorrhagic disease in rabbits, J. Virol., 64, 4013, 10.1128/JVI.64.8.4013-4015.1990 Peiperl, 2010, Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054), PLoS ONE, 5, e13579, 10.1371/journal.pone.0013579 Pérez-Filgueira, 2007, Development of a low-cost, insect larvae-derived recombinant subunit vaccine against RHDV, Virology, 364, 422, 10.1016/j.virol.2007.03.016 Sánchez, 2007, The goat mammary glandular epithelial (GMGE) cell line promotes polyfucosylation and N,N′-diacetyllactosediaminylation of N-glycans linked to recombinant human erythropoietin, Arch. Biochem. Biophys., 464, 322, 10.1016/j.abb.2007.04.027 Sánchez, 2010, Avian CD154 enhances humoral and cellular immune responses induced by an adenovirus vector-based vaccine in chickens, Comp. Immunol. Microbiol. Infectious Dis., 28, 7907 Santuosso, 2006, Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis, Infect. Immun., 74, 4634, 10.1128/IAI.00517-06 Schirrmeier, 1999, Pathogenic, antigenic and molecular properties of rabbit haemorrhagic disease virus (RHDV) isolated from vaccinated rabbits: detection and characterization of antigenic variants, Arch. Virol., 144, 719, 10.1007/s007050050538 Sun, 2010, Generation and efficacy evaluation of a recombinant adenovirus expressing the E2 protein of classical swine fever virus, Res. Vet. Sci., 88, 77, 10.1016/j.rvsc.2009.06.005 Suzuki, 2010, Large-scale production of high-quality helper-dependent adenoviral vectors using adherent cells in cell factories, Hum. Gene Ther., 21, 120, 10.1089/hum.2009.096 Toledo, 2006, High expression level of recombinant human erythropoietin in the milk of non-transgenic goats, J. Biotechnol., 123, 225, 10.1016/j.jbiotec.2005.10.019 Toledo, 2008, Highly protective E2-CSFV vaccine candidate produced in the mammary gland of adenoviral transduced goats, J. Biotechnol., 133, 370, 10.1016/j.jbiotec.2007.09.014 Tucker, 2008, Oral adenoviral-based vaccines: historical perspective and future opportunity, Expert Rev. Vaccines, 7, 25, 10.1586/14760584.7.1.25 Wesley, 2005, Evaluation of a recombinant human adenovirus-5 vaccine administered via needle-free device and intramuscular injection for vaccination of pigs against swine influenza virus, Am. J. Vet. Res., 66, 1943, 10.2460/ajvr.2005.66.1943